Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
5-alfa-reductaseremmers geassocieerd met minder COVID-19-symptomen bij mannen met alopecia androgenetica
feb 2021 | Virale infecties